You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Inclisiran sodium

Showing 1 - 25 of 3,060
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Inclisiran on Major Adverse Cardiovascular Events in French

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • Inclisiran sodium
  • +3 more
  • (no location specified)
Jul 26, 2023

Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)

Not yet recruiting
  • Primary Prevention of Atherosclerotic Cardiovascular Disease
  • Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
  • Placebo in 1.5ml
  • (no location specified)
Feb 13, 2023

Hyperlipidemia Trial in Changsha, Chengdu, Beijing (100 mg inclisiran sodium (equivalent to 94.5 mg inclisiran), Placebo, 300 mg

Completed
  • Hyperlipidemia
  • 100 mg inclisiran sodium (equivalent to 94.5 mg inclisiran)
  • +2 more
  • Changsha, Hunan, China
  • +2 more
Dec 2, 2021

Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density

Active, not recruiting
  • Atherosclerotic Cardiovascular Disease
  • +2 more
  • Sale, Cheshire, United Kingdom
  • +16 more
Jan 20, 2023

Coronary Artery Disease Trial in Worldwide (Inclisiran sodium 300 mg, Placebo)

Recruiting
  • Coronary Artery Disease
  • Inclisiran sodium 300 mg
  • Placebo
  • Huntsville, Alabama
  • +54 more
Jan 31, 2023

Hypercholesterolemia Trial in Worldwide (inclisiran sodium, Placebo)

Active, not recruiting
  • Hypercholesterolemia
  • inclisiran sodium
  • Placebo
  • Lanzhou, Gansu, China
  • +44 more
Feb 7, 2022

Heterozygous or Homozygous Familial Hypercholesterolemia Trial (Inclisiran)

Not yet recruiting
  • Heterozygous or Homozygous Familial Hypercholesterolemia
  • (no location specified)
Dec 27, 2022

Primary Hypercholesterolemia or Mixed Dyslipidemia Trial (Inclisiran, Matching Placebo for Inclisiran)

Not yet recruiting
  • Primary Hypercholesterolemia or Mixed Dyslipidemia
  • (no location specified)
May 24, 2023

Hypercholesterolemia Trial (Inclisiran, Ezetimibe, Matching Placebo for Inclisiran)

Not yet recruiting
  • Hypercholesterolemia
  • (no location specified)
Feb 28, 2023

Acute Coronary Syndrome Trial in United States (Inclisiran)

Recruiting
  • Acute Coronary Syndrome
  • Huntsville, Alabama
  • +77 more
Jan 13, 2023

Atherosclerotic Cardiovascular Disease Trial in United States (Inclisiran)

Recruiting
  • Atherosclerotic Cardiovascular Disease
  • Little Rock, Arkansas
  • +43 more
Jan 20, 2023

Familial Hypercholesterolemia - Heterozygous Trial in Worldwide (Inclisiran, Placebo)

Recruiting
  • Familial Hypercholesterolemia - Heterozygous
  • Tucson, Arizona
  • +76 more
Aug 8, 2022

Atherosclerotic Cardiovascular Disease Trial in Boston, Oxford (Inclisiran, Placebo)

Recruiting
  • Atherosclerotic Cardiovascular Disease
  • Boston, Massachusetts
  • +1 more
Mar 1, 2022

Heterozygous Familial Hypercholesterolemia, Elevated Cholesterol Trial in Worldwide (Inclisiran, Placebo)

Completed
Has Results
  • Heterozygous Familial Hypercholesterolemia
  • Elevated Cholesterol
  • Mission Viejo, California
  • +44 more
Oct 6, 2020

ASCVD, Elevated Cholesterol, Heterozygous Familial Hypercholesterolemia Trial in Worldwide (Inclisiran Sodium)

Active, not recruiting
  • ASCVD
  • +3 more
  • Inclisiran Sodium
  • Birmingham, Alabama
  • +237 more
Jan 26, 2022

ASCVD, Risk Factor, Cardiovascular, Elevated Cholesterol Trial in Worldwide (Inclisiran Sodium, Placebo)

Completed
Has Results
  • ASCVD
  • +2 more
  • Inclisiran Sodium
  • Placebo
  • Chomutov, Czechia
  • +69 more
Aug 3, 2020

ASCVD, Elevated Cholesterol Trial in United States (Inclisiran Sodium, Placebo)

Completed
Has Results
  • ASCVD
  • Elevated Cholesterol
  • Inclisiran Sodium
  • Placebo
  • Birmingham, Alabama
  • +144 more
Sep 8, 2020

Inclisiran and Other Lipid Lowering Treatments inReal-world

Recruiting
  • Hypercholesterolemia
  • Inclisiran
  • Freudenstadt, Baden Wuerttemberg, Germany
  • +94 more
Jan 24, 2023

The Belgian REAL (BE.REAL) Registry

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • Inclisiran
  • (no location specified)
Feb 3, 2023

German Inclisiran Network: Retrospective Registry of Patients

Recruiting
  • Hypercholesterolemia
    • Jena, Germany
      Jena University Hospital
    Jul 4, 2022

    Lipoprotein(a) and Endogenous Fibrinolysis in Atherosclerotic

    Recruiting
    • Atherosclerosis
    • Aortic Valve Disease
    • Thrombotic assessment
    • Measurement of Lp(a)
    • Stevenage, United Kingdom
      East and North Herts NHS Trust
    Nov 6, 2023

    Inclisiran Among Early Users in Germany

    Completed
    • High Levels of Low-density Lipoprotein Cholesterol
      • Basel, Switzerland
        Novartis
      May 12, 2023

      Inclisiran in Chinese Adult Primary Hypercholesterolemia or

      Recruiting
      • Primary Hypercholesterolemia
      • Mixed Dyslipidemia
      • Inclisiran
      • Haikou, Hainan, China
      • +2 more
      Jun 13, 2022

      Inclisiran Plus Standard of Care Lipid-lowering Therapy Compared

      Recruiting
      • Primary Hypercholesterolemia
      • Mixed Dyslipidemia
      • Inclisiran
      • Geneve 14, Switzerland
        Novartis Investigative Site
      Nov 14, 2022

      Hypercholesterolemia, Atherosclerotic Ischemic Disease Trial in Heidelberg, London (lerodalcibep, Inclisiran)

      Enrolling by invitation
      • Hypercholesterolemia
      • Atherosclerotic Ischemic Disease
      • Nantes, Cedex 01, France
      • +6 more
      Nov 3, 2022